CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024. In the quarter to June 2026, revenue grew 52.2%, EPS grew 1,443.8% and free cash flow grew 223.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

63.81 2.87 −4.30%
Market cap
$3.5B
P/E
29.7×
Fwd P/E
2,967×
Dividend yield
—
F-score
5/9
Altman Z
4.14
Beneish M
−3.36
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

11.18 0.00 0.00 13.26
P/S ratio
2.13 2.64 2.15 3.20
P/FCF ratio
21.49 29.06 14.03 17.64
P/Operating CF
20.44 46.99 204.94 47.93
P/B ratio
2.45 3.31 2.83 3.45
EV/Sales
1.60 2.18 1.70 2.39
EV/EBITDA
6.91 0.00 118.53 8.43
EV/FCF
16.09 24.00 11.11 13.18
Current Ratio
3.03 2.86 3.40 4.58
Net Debt/EBITDA
(23.96) 54.39 (25.20) (3.17)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
8.94% (2.12%) (0.92%) 7.54%
Free Cash Flow Yield
4.65% 3.44% 7.13% 5.67%
Free Cash Flow per Share
0.67 0.36 0.01 0.56
Book value per Share
5.93 5.69 6.13 8.27
Free Cash Flow
35.38 19.39 0.51 28.75
EV/EBIT
9.59 0.00 0.00 10.13
Other line items

Show all line items

Columns are period end dates